- Time: 11:00am - 3:00pm
- Track: Clinical Practice
- CME/CE: 4.0
Additional Fee Session
Sponsored by the Alcohol, Tobacco, and Other Drug Use (ATOD) Among Older Adults Special Interest Group
Moderator: Michael Fingerhood, MD
Speakers: Benjamin Han, MD, MPH; Linda R. Mitchell, MD; Justina L. Groeger, MD, MPH; Vassiliki Pravodelov, MD
Opioid use disorder increasingly affects older adults, yet treatment for opioid use disorder remains poorly integrated into settings where geriatric patients routinely receive care. Buprenorphine is one of three medications approved by the FDA to treat opioid use disorder, is highly effective, safe in older adults, and can be prescribed by primary care clinicians. Yet a paucity of primary care clinicians and geriatricians are waivered to prescribe buprenorphine. After completing this 4-hour virtual training, participants will receive the second half of the course – a 4-hour online self-study portion. At the end of the course, participants are required to pass an exam with a 75% or higher before applying for their waiver to prescribe buprenorphine in the United States under the Drug Addiction Treatment Act of 2000 (DATA 2000). This training will also have a special focus on buprenorphine prescribing for older adults. The training is open to physicians, nurse practitioners (NP), and physician assistants (PA) however NP/PA need to complete more hours of training beyond this course (24 hours total) per the 2016 Comprehensive Addiction and Recovery Act (CARA) requirements. Learning Objectives: (1) list factors important to patient selection for office-based buprenorphine treatment; (2) identify the clinically relevant pharmacological characteristics of buprenorphine, methadone, and naltrexone; and (3) describe the resources needed to establish office-based treatment with buprenorphine and other medications for patients with opioid use disorders.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.